Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis - Wu, Junfang; Zhao, Mingming; Wei, Haoran; Li, Chenze; Hu, Dong; Zheng, Lemin; Wang, Dao Wen (European heart journal. Cardiovascular pharmacotherapy, 2022)
Keywords: Analysis; China; Clinical outcomes; Coronaviruses; COVID-19; Hospital patients; Infection; Inhibitor drugs; Liver; Mortality; Original; Patient outcomes; China; COVID-19; Neuraminidase inhibitor; acetylneuraminic acid; N-acetylneuraminic acid